Bristol-Myers Squibb Co BMY

NYSE US Health Care Pharmaceuticals

$62.86 ▼ -1.60% ($-1.02)

Index member: S&P 500

Open $63.58

Prev Close $63.88

Day Range $61.95 – $63.89

52W Range $42.52 – $68.64

Market Cap $125.63B

P/E (TTM) 13.92

Beta 0.19

Div Yield 4.58%

EPS (TTM) $4.54

📋 Company Profile

Industry	Pharmaceuticals
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	1980-03-17
Shares Out.	2,042,070,000
Website	bms.com ↗
Phone	13026587581
Employees	32,500
Revenue	$12.97B
Gross Profit	$9.25B
Net Income	$3.32B
Free Cash Flow	$11.44B
Total Assets	$87.63B
Total Liabilities	$65.32B
Equity	$22.32B

About Bristol-Myers Squibb Co

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co is a publicly traded company under the ticker symbol BMY on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.